Consequently, restoration of TIMP3 expression in mouse models of non-alcoholic steatohepatitis (NASH) reduced ADAM17 activity and lowered fibrotic activity in the liver, suggesting that ADAM17 is essential for NASH pathology [68]. The gene discussed is ADAM17; the disease is metabolic dysfunction-associated steatohepatitis.